1. Guan T, Guo XY, Ye CL, Jiang YH. Analysis of circulating DNA level in the plasma of cervical cancer patients. Nan Fang Yi Ke Da Xue Xue Bao. 2008;28:1663–4. 1667
2. Wang H, Pan SY, Xu J, et al. Study of quantitative detection of circulating DNA in the plasma of patients with cervical lesion. Zhonghua Fu Chan Ke Za Zhi. 2011;46:501–4.
3. Wang H, Pan SY, Pang ZR, et al. Quantitative detection of APC/RASSF1A promoter methylation in the plasma of patients with cervical diseases. Zhonghua Fu Chan Ke Za Zhi. 2013;48:929–34.
4. Widschwendter A, Muller HM, Fiegl H, et al. DNA methylation in serum and tumors of cervical cancer patients. Clin Cancer Res. 2004;10:565–71.
5. Widschwendter A, Ivarsson L, Blassnig A, et al. CDH1 and CDH13 methylation in serum is an independent prognostic marker in cervical cancer patients. Int J Cancer. 2004;109:163–6.